Drug Approvals
🇺🇸 FDA Page 22FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 253–264 of 665 articles
Latest Developments on Ebola, Hepatitis B, and Long Covid
FDA PreCheck Pilot Program Launches: A New Era for Clinical Trials
GSK and Ionis Present Promising Hepatitis B Drug Data
AstraZeneca's Imfinzi Secures Second Bladder Cancer Approval
Seven Biopharma Trends to Watch in 2026: Clinical Trials Insights
FDA Approves Durvalumab and BCG for High-Risk NMIBC
Research Progress and Development Strategies of Antibody-Oligonucleotide Conjugates
FDA Alert: Infectious Diseases Drug News Roundup 2026
Experimental IgG4-RD Drug Submission to FDA After Successful Trial
Leap Therapeutics Stock Edges Higher After Recent Data
Ebola Outbreak Response: U.S. Fortification Strategies
Biopharma Dealmaking in 2025: Market Analysis